These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1357898)

  • 1. Hemolytic uremic syndrome in a patient with systemic sclerosis treated with cyclosporin A.
    Zachariae H; Hansen HE; Olsen TS
    Acta Derm Venereol; 1992 Aug; 72(4):307-9. PubMed ID: 1357898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A.
    Chen WS; Young AH; Wang HP; Huang DF
    Rheumatol Int; 2009 May; 29(7):821-4. PubMed ID: 19156422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient.
    Abdalla AH; al-Sulaiman MH; al-Khader AA
    Transpl Int; 1994 Aug; 7(5):382-4. PubMed ID: 7527640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma renal crisis complicated by hemolytic uremic syndrome in a case of elderly onset systemic sclerosis.
    Yamanaka K; Mizutani H; Hashimoto K; Nishii M; Shimizu M
    J Dermatol; 1997 Mar; 24(3):184-8. PubMed ID: 9114617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient.
    Galli FC; Damon LE; Tomlanovich SJ; Keith F; Chatterjee K; DeMarco T
    J Heart Lung Transplant; 1993; 12(3):440-4. PubMed ID: 8329415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin-associated thrombotic microangiopathy: successful retreatment with cyclosporin.
    Bolin P; Jennette JC; Mandel SR
    Ren Fail; 1991; 13(4):275-8. PubMed ID: 1780496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma renal crisis as a possible complication of cyclosporin A withdrawal.
    Casoli P; Carretti C; Tumiati B
    Clin Rheumatol; 1994 Mar; 13(1):126-8. PubMed ID: 8187435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of early onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Kim W; La BJ; Lee S; Yu HC; Cho BH; Kang MJ; Park SK
    Clin Nephrol; 2003 Feb; 59(2):148-50. PubMed ID: 12608560
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemolytic and uremic syndrome after heart transplantation.
    Mercadal L; Petitclerc T; Assogba U; Beaufils H; Deray G
    Am J Nephrol; 2000; 20(5):418-20. PubMed ID: 11093002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 expression in scleroderma renal crisis.
    Mouthon L; Mehrenberger M; Teixeira L; Fakhouri F; Bérezné A; Guillevin L; Noël LH
    Hum Pathol; 2011 Jan; 42(1):95-102. PubMed ID: 20971496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reproducibility of cyclosporin-induced hemolytic uremic syndrome in a renal allograft recipient.
    Ok E; Kursat S; Tokat Y; Cirit M; Tombuloglu M; Akcicek F
    Nephron; 1996; 74(1):238. PubMed ID: 8883059
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases.
    Denton CP; Sweny P; Abdulla A; Black CM
    Br J Rheumatol; 1994 Jan; 33(1):90-2. PubMed ID: 8162467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura in a patient with Behçet's disease treated with cyclosporin.
    Docci D; Baldrati L; Capponcini C; Facchini F; Giudicissi A; Feletti C
    Nephron; 1997; 75(3):356-7. PubMed ID: 9069461
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
    Abraham KA; Little MA; Dorman AM; Walshe JJ
    Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normotensive scleroderma renal crisis: case report and review of the literature.
    Haviv YS; Safadi R
    Ren Fail; 1998 Sep; 20(5):733-6. PubMed ID: 9768442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome.
    Richardson D; Jones CH; Newstead CG; Will EJ; Lodge JP
    Nephrol Dial Transplant; 1996 Dec; 11(12):2498-500. PubMed ID: 9017633
    [No Abstract]   [Full Text] [Related]  

  • 17. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
    Wen YK; Chen ML
    Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome.
    Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
    Transpl Int; 1998; 11 Suppl 1():S98-9. PubMed ID: 9664954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uneventful re-treatment with cyclosporin in two cases of cyclosporin-induced haemolytic uraemic syndrome.
    Guella A; Daoud M; Al Dayel A
    Nephrol Dial Transplant; 1998 Jul; 13(7):1864-5. PubMed ID: 9681750
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome.
    Said T; al-Mousawi M; Samhan M; Lao M
    Transplant Proc; 1999 Dec; 31(8):3295-7. PubMed ID: 10616482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.